{"_id":"YNQza1Ae8Mnhn2CdN3KBWVVF9UvtVofWogPC6U1GSAzg2SfOsvOJWu","lastupdate":"2023-08-24T00:00:00.000Z","update_date":"2023-08-24T00:00:00.000Z","lastModified":"Dec 18, 2024","active":1,"confidence_score":72,"confidence_score_reason":"sector, tags, video or image, markets, not claimed","urlname":"promise-bio","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$ahhNY6c4UzKvRwHtYi2573k2aGLuswBIqHtUsxrRdILZcpqUdBd33p.jpeg","name":"Promise Bio","oneliner":"Epiproteomic Analyses on standard Mass-Spectrometry Data","registrar":"516749298","website":"https://www.promise.bio/","careerspage":"","founded_month":1,"founded_year":2023,"formernames":[],"sociallinks":{"twitter":"","youtube":"","facebook":"","linkedin":"https://www.linkedin.com/company/82083896","instagram":""},"social":["https://www.linkedin.com/company/82083896"],"flattenedsociallinks":"https://www.linkedin.com/company/82083896","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":null,"employees":"11-50","employees_exact":14,"patent":null,"raised":9000000,"stage":"Seed","public_stage":"Seed","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":null,"about":"Promise Bio, a recent spin-out from the Weizmann Institute, is the first company to harness post-translational modifications (PTM) and artificial intelligence to reveal unique biological insights that are otherwise overlooked.\nUnderstanding immune-mediated diseases requires uncovering intricate proteomic patterns, and PTMs are the key to capturing the regulated part of the proteome.\n\nThe PROMISE platform uses proprietary Comprehensive PTM Profiling to detect up to 45 PTM types simultaneously, allowing maximal knowledge extraction from biological data and offering a unique approach to identifying functional biomarkers from diverse biological samples (PBMCs, tissue biopsies, urine). With a proprietary technology recently published in Nature Biotechnology, we partner with pharmaceutical companies to unleash the potential of their data-driven discovery, by looking at biology where it matters the most for complex chronic diseases.","climatetech_description":null,"is_climatetech_relevant":null,"phone":null,"country":null,"address":{"israeli":[{"id":"uI1jDPrg8aRkWfyKxHSAyxTqw84MYW5yXuWeNsEUlWsqssrPMrNxqk","city":"Tel Aviv-Yafo","type":null,"address":"Tel Aviv-Yafo, Israel","placeid":"ChIJH3w7GaZMHRURkD-WwKJy-8E","notactive":null,"openeddate":null,"registrarid":null,"firstrdcenter":null,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":null,"news":[{"id":"2eXC06xMyL7i4917aQXXKZgAETnVoAFlglBhaBoMkjqxksASd21Ozu","date":"Dec 16, 2024","link":"https://www.calcalistech.com/ctechnews/article/bk7gpunvyl","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"precision medicine","company":"Promise Bio","layoffs":null,"summary":"Promise Bio, a startup focused on treating immune-mediated diseases with precision medicine, has emerged from stealth with an $8.3 million Seed investment. The funding round was led by Awz Ventures and included contributions from AstraZeneca, Pfizer, and the Israel Innovation Authority. This investment will accelerate the development of Promise Bios computational platform, which leverages epiproteomics and AI to predict patient treatment responses and support drug research. The platform, based on research by Dr. Assaf Kacen at the Weizmann Institute of Science, aims to improve the effectiveness of autoimmune disease treatments by focusing on protein modifications. The company seeks to eliminate the trial-and-error approach in current treatments, which only achieve significant remission in 30-40% of patients.","partners":null,"customers":null,"investors":["Awz Ventures","AstraZeneca","Pfizer","Israel Innovation Authority"],"confidence":9,"key_topics":["immune diseases","precision medicine","protein modifications","AI","investment"],"date_of_event":"Not explicitly mentioned","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$8.3 million","structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"MyQ7ZoJ9cDhDEkj2pg9gHpWVnWbfBhKhPjoYRxGSOaYIoKR0TAW4yM","news_summary":"The Israeli startup's computational platform uses epiproteomics and AI to predict patient treatment responses and support drug research and development.","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"kwE54FxXerQtiJGbR5CP0j0PU379BIM0MtJyaYyhlUcSYADwLOoqJh","date":"Dec 16, 2024","link":"https://www.prnewswire.com/il/news-releases/promise-bio-emerges-from-stealth-with-8-3m-seed-investment-to-transform-precision-medicine-for-immune-mediated-diseases-302331966.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"precision medicine","company":"Promise Bio","layoffs":null,"summary":"Promise Bio, a startup focused on precision medicine for immune-mediated diseases, has emerged from stealth with an $8.3 million seed investment. The funding, led by Awz Ventures and supported by AION Labs, AstraZeneca, and Pfizer, will accelerate the development of Promise Bios platform that integrates epiproteomics and AI to predict patient treatment responses. The company aims to transform treatment approaches by focusing on protein modifications and leveraging machine learning. Strategic partnerships with leading biopharmaceutical companies provide financial backing and industry expertise, positioning Promise Bio to advance precision medicine solutions and build the worlds largest PTM database.","partners":["AstraZeneca","Pfizer"],"customers":null,"investors":["Awz Ventures","AION Labs","AstraZeneca","Pfizer"],"confidence":9,"key_topics":["epiproteomics","AI","biomarkers","immune diseases","precision medicine"],"date_of_event":"2023","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$8.3 million","structured_issues":["Investment","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"GkeNFjTsr19l1tm0xIzIv1mVJSZzZQbAWvWxskCSbirUi7GQN6orHM","news_summary":"/PRNewswire/ -- Promise Bio, a startup transforming immune-mediated disease treatment with advanced precision medicine solutions, today announced its emergence...","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":2,"techcommunityinvolvement":null,"mediagallery":[],"tags":[],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B"],"productstage":"R&D","products":[],"geomarkets":[],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":2,"lastfunding":"$8.3M","totalrounds":2,"fundingstage":"Seed","totalfunding":"$9M","publicinvestors":2,"lastpublicfunding":8300000,"totalpublicrounds":2,"totalpublicfunding":9000000},"team":[{"name":"Ronel  Veksler","email":"ronel@promisebio.co","phone":"","gender":"Male","userid":"v6KtkGjXGyNzp8ZvZ6NavUUU0T7wTQmnmeCfDnZV84621IHqpr98ra","bounced":false,"claimed":null,"founder":1,"urlname":"ronel-veksler","visible":1,"memberid":"Kk1ba9TM0EdaumBt7BbIn1Ve9iSDIzBjIJFMKaDtGb8AfnKUGy3UQ0","position":"Co-founder & CEO","last_name":"Veksler","claimtoken":null,"first_name":"Ronel ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/ronelveksler/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":null,"initials":"RV","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":null,"tag_line_edited":null,"sector":null,"sectorverify":null,"biverify":{"id":"c9EsgAuuvwml0IzyIKWmOxLUUF5GjptiIXjHR1tp2gTB0O2GoGTfCd","fullname":"Yanina Wainscheinker"},"biverifydate":"2023-08-24T00:00:00.000Z","crunchbaseid":null,"lastupdator":null,"lastupdator_email":null,"creator":"Yanina Wainscheinker","creator_email":"yanina.wainscheinker@sncentral.org","createdate":"2023-08-24T00:00:00.000Z","biverification":"Yanina Wainscheinker","sectorverification":null,"affiliatedOrganizations":null,"timeline":[{"id":"n39CGqkrZhs4HsGd2PMHAhZHPazzY9NiVXDpfoDzVVzfS3sQjU0Egs","date":"Dec 2024","amount":"$8.3M","source":"https://www.calcalistech.com/ctechnews/article/bk7gpunvyl","eventtype":"FundingRoundEvent","investment":[{"name":"Awz Ventures","type":"Investor","amount":null,"hidden":false,"country":"Canada","fullurl":"/investor_page/awz-ventures","logokey":"$D93ARLygH0jZmDfrNi8qKth0nmUkyGScdVj0G2AdKTFvZBg0BTgCCJ","tagline":null,"urlname":"/investor_page/awz-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4I3FlMMIDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"HnRIO3030U6fbx8uth1SLyzpcVucGnl8viz3PwyVssKcXB1ck2nJ3H","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$D93ARLygH0jZmDfrNi8qKth0nmUkyGScdVj0G2AdKTFvZBg0BTgCCJ","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"Lead ","followupcaption":""},{"name":"AION Labs","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/aion-labs","logokey":"$1FOImCyTbdd2u8SHf1WVYGKnxrILHUTllRJ634zbzaLIDsBQzg9aT8","tagline":null,"urlname":"/investor_page/aion-labs","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAkJD3oO8IDA","fundingtype":"Incubator","leadpartner":null,"investmentid":"tpB5WdUM01qg1ZbgBncSfMKgivwr5VDBynem2NcsXQvwdursDqvuoS","fundingsubtype":"Incubator","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$1FOImCyTbdd2u8SHf1WVYGKnxrILHUTllRJ634zbzaLIDsBQzg9aT8","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":8300000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"9w3hobFZQ9Aopqpn46fVZklHnUrjKZQJaQpm7rZcVT4AB2t4kIWikX","date":"Jan 2024","amount":"$700K","source":"Mati Gill, Aion labs","eventtype":"GrantEvent","granttype":1,"investment":[{"name":"Israel Innovation Authority ","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/israel-innovation-authority-1","logokey":"$3Fnyw6sWSY0hZOuxYHCPlbAw21MX276wA1ASUaacUlwfZPModDvmko","tagline":"Governmental grant for POC ","urlname":"/investor_page/israel-innovation-authority-1","isisraeli":1,"investorid":"8TrglTPuxDd2ABfwzfoRPSHOLbGlGXhvTxe0CF3zKPbddG3xPprg1h","fundingtype":"Grant Provider","leadpartner":null,"investmentid":"UlfV8rS6vKHJE02NRzWTgYBPxIKGj9UmnFMC54aYwHT2nfSLAtXoAI","fundingsubtype":"Grant Provider","investorislead":0,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$3Fnyw6sWSY0hZOuxYHCPlbAw21MX276wA1ASUaacUlwfZPModDvmko","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":700000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"1/2023","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Promise Bio","logourl":"https://storage.googleapis.com/clean-finder-353810/$ahhNY6c4UzKvRwHtYi2573k2aGLuswBIqHtUsxrRdILZcpqUdBd33p.jpeg","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$ahhNY6c4UzKvRwHtYi2573k2aGLuswBIqHtUsxrRdILZcpqUdBd33p.jpeg","seoabout":"Promise Bio, a recent spin-out from the Weizmann Institute, is the first company to harness post-translational modifications (PTM) and artificial intellige...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":1,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drugs Discovery & Development","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Artificial Intelligence","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"}],"classificationDelimited":["TechnologyClassificationModel>Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA>Drugs Discovery & Development#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA>Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA"],"classificationsViewModel":"|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA|1:>TechnologyClassificationModel/Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA/Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA/Drugs Discovery & Development#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Pharma & Medical Biotechnology","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology","children":[{"title":"Drugs Discovery & Development","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology>Drugs Discovery & Development"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Life Sciences","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences","children":[{"title":"Pharmaceuticals","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences>Pharmaceuticals"}]}]}],"coreTechnology":[{"title":"Artificial Intelligence","key":"0-0","path":"TechnologyClassificationModel>Artificial Intelligence"},{"title":"Biologicals","key":"0-1","path":"TechnologyClassificationModel>Biologicals"}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drugs Discovery & Development","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Artificial Intelligence","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Pharma & Medical Biotechnology","Drugs Discovery & Development"],"coreTechnology":["Artificial Intelligence","Biologicals"],"targetCustomer":["Healthcare & Life Sciences","Life Sciences","Pharmaceuticals"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"n39CGqkrZhs4HsGd2PMHAhZHPazzY9NiVXDpfoDzVVzfS3sQjU0Egs","date":"Dec 2024","amount":"$8.3M","source":"https://www.calcalistech.com/ctechnews/article/bk7gpunvyl","eventtype":"FundingRoundEvent","investment":[{"name":"Awz Ventures","type":"Investor","amount":null,"hidden":false,"country":"Canada","fullurl":"/investor_page/awz-ventures","logokey":"$D93ARLygH0jZmDfrNi8qKth0nmUkyGScdVj0G2AdKTFvZBg0BTgCCJ","tagline":null,"urlname":"/investor_page/awz-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4I3FlMMIDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"HnRIO3030U6fbx8uth1SLyzpcVucGnl8viz3PwyVssKcXB1ck2nJ3H","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$D93ARLygH0jZmDfrNi8qKth0nmUkyGScdVj0G2AdKTFvZBg0BTgCCJ","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"Lead ","followupcaption":""},{"name":"AION Labs","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/aion-labs","logokey":"$1FOImCyTbdd2u8SHf1WVYGKnxrILHUTllRJ634zbzaLIDsBQzg9aT8","tagline":null,"urlname":"/investor_page/aion-labs","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAkJD3oO8IDA","fundingtype":"Incubator","leadpartner":null,"investmentid":"tpB5WdUM01qg1ZbgBncSfMKgivwr5VDBynem2NcsXQvwdursDqvuoS","fundingsubtype":"Incubator","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$1FOImCyTbdd2u8SHf1WVYGKnxrILHUTllRJ634zbzaLIDsBQzg9aT8","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":8300000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[{"id":"9w3hobFZQ9Aopqpn46fVZklHnUrjKZQJaQpm7rZcVT4AB2t4kIWikX","date":"Jan 2024","amount":"$700K","source":"Mati Gill, Aion labs","eventtype":"GrantEvent","granttype":1,"investment":[{"name":"Israel Innovation Authority ","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/israel-innovation-authority-1","logokey":"$3Fnyw6sWSY0hZOuxYHCPlbAw21MX276wA1ASUaacUlwfZPModDvmko","tagline":"Governmental grant for POC ","urlname":"/investor_page/israel-innovation-authority-1","isisraeli":1,"investorid":"8TrglTPuxDd2ABfwzfoRPSHOLbGlGXhvTxe0CF3zKPbddG3xPprg1h","fundingtype":"Grant Provider","leadpartner":null,"investmentid":"UlfV8rS6vKHJE02NRzWTgYBPxIKGj9UmnFMC54aYwHT2nfSLAtXoAI","fundingsubtype":"Grant Provider","investorislead":0,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$3Fnyw6sWSY0hZOuxYHCPlbAw21MX276wA1ASUaacUlwfZPModDvmko","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":700000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"merger_acquisitions":[],"others":[]}}